Product Information
CLOTRIMAZOLE-BETAMETHASONE CRM is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.2013 per GM under NDC 51672404801. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 29, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; 10 mg/g; mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672404801
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA075673FDA Approved
5/29/2001
TE Code
AB
On Market Since
5/29/2001
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2013 per GM |
|---|---|
| All-time high | $1.1355 (Feb 12, 2014) |
| All-time low | $0.1931 (May 22, 2024) |
| 52-week high | $0.2265 |
| 52-week low | $0.2013 |
| Median price | $0.3188 |
| Average price | $0.4588 |
| Largest weekly change | +37.7% (Dec 23, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clotrimazole and Betamethasone Dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE-BETAMETHASONE CRM?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE-BETAMETHASONE CRM, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.2013 per GM (NDC 51672404801), effective Sep 30, 2026.
How has the price of CLOTRIMAZOLE-BETAMETHASONE CRM changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has declined 81.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE-BETAMETHASONE CRM?
Since Nov 28, 2013, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has ranged from a low of $0.1931 (May 22, 2024) to a high of $1.1355 (Feb 12, 2014), with a median of $0.3188 per GM.
Are there cheaper alternatives to CLOTRIMAZOLE-BETAMETHASONE CRM?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOTRIMAZOLE-BETAMETHASONE CRM, is $0.1781 per GM — about 12% below CLOTRIMAZOLE-BETAMETHASONE CRM.
Who manufactures CLOTRIMAZOLE-BETAMETHASONE CRM?
CLOTRIMAZOLE-BETAMETHASONE CRM (NDC 51672404801) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.